Leptin has also been found to drive metastasis in both an ER+ and ER- context, with leptin knockout in obese ASCs resulting in reduced motility of BC cell lines in vitro and reduced metastasis in an in vivo patient-derived xenograft model of TNBC (5, 87). Here, LEP is linked to breast cancer.